Lorimer Wilson | TalkMarkets | Page 1
Editor of munKNEE.com (A site for sore eyes and inquisitive minds)
Contributor's Links: munKNEE
Lorimer is one of TalkMarkets' most prolific contributors with +2600 articles, +7100 followers and more than 20 million equity points to date. He focuses on AI, cannabis and psychedelic compound-based clinical stage stocks. Sign up to follow his latest articles and have your say in the Comment ...more

All Contributions

Latest Posts
1 to 16 of 2613 Posts
1 2 3 ... 164 >>>
AI Small Cap Stocks Portfolio Jumped +6% Last Week Led By VRSSF
The AI Small Cap Stocks Portfolio declined 23% in April but rebounded since then going UP 2.5% w/e May 3rd, UP 3.0% w/e May 10th, UP 8.7% w/e May 17th and UP 6.5% last week. This article highlights the performances of the Portfolio's 10 constituents,
AI Category Returns Were A Mixed Bag This Week
The 7 AI categories tracked by munKNEE.com went UP 1.5% this week on top of a 2.9% advance the previous week with 3 categories advancing, 3 declining and one with no change.
Update: Ai Pin Widely Panned; Humane Announces It's For Sale
Humane, after just over 6 months on the market with its Ai Pin product, is already hunting for a potential buyer for its business and is seeking a price of between $750 million and $1 billion but the poor reviews of the device make that unlikely.
These AI Stocks Have Momentum Up And Down
You can produce consistent gains by rigorously buying and selling stocks using the relative strength index.
Microsoft Has Joined 4 Other AI PC Manufactures With Two Copilot+ PC Models
Microsoft has introduced its first Copilot+ PCs to support upcoming AI features in Windows 11. 
A $50B AI Drug Discovery Revolution Has Begun - Here Are 6 Stocks To Consider Investing In
The drug development process is very expensive and time-consuming which creates a huge shortage in drug candidates and programs but the advent of AI can significantly shorten and cheapen this process and this is already happening.
Another AI Category To Take Notice Of: High Band Memory Chip Manufacturers
High Band Memory (HBM), in simple terms, is a certain number of conventional DRAM (direct random-access memory) chips stacked together to achieve greater performance and efficiency.
AI Small Cap Stocks Portfolio Jumped 9% Last Week, Led By AAOI
Our AI Small Cap Stocks Portfolio declined 23% in April but has rebounded since then, gaining momentum each week. Here we highlight the performances of the Portfolio's 10 constituents..
American Cannabis MSOs Portfolio Reversed Direction Last Week
This article highlights how each constituent in the Portfolio fared last week and MTD along with their reported Q1 profit or loss and their Q1 adjusted EBITDA as a percentage of quarterly revenue for comparison purposes:
Canadian Cannabis LPs Portfolio Up 14% This Week; Still Down 21% MTD
The Portfolio was up 14.1% this week but is still finding its level, off almost 21% from its spike from the April 30th DEA announcement.
All 7 Artificial Intelligence (AI) Categories Reversed Direction This Week
All 7 of the AI categories we track were up 2.9%, on average, this week.
AI Small Cap Stocks Portfolio Up 3% W/e May 10th; Still Down 26% YTD
AI Small Cap Stocks Portfolio declined 23% in April but was up 2.5% w/e May 3rd and another 3.0% w/e May 10th.
AYR Wellness' Q1 Financials Reveal 94% Reduction In Net Loss
First quarter results reflect continued progress with modest sequential revenue growth, adjusted EBITDA margins in line with long-term targets of 25% and positive free cash flow for the period.
All Cresco Labs' QI Financial Metrics Down Except SG&A
Despite the poor Q1 financial report Cresco's stock price is UP 2.5% as of mid-day but is still DOWN 1.9% from last Friday albeit UP 52.6% YTD.
Organigram Q2 Financial Metrics Mixed
Of the top 3 licensed producers in Canada Organigram is the only one with significant cash, negligible debt, and sizeable funds earmarked for strategic international investment.
Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
This article highlights the performance last week of the 10 clinical-stage AI-powered and psychedelic compound-based drug discovery companies in the munKNEE Clinical-Stage BioTech Drug Stocks Portfolio,
1 to 16 of 2613 Posts
1 2 3 ... 164 >>>